These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35105713)

  • 1. COVID-19 Hospitalizations, Intensive Care Unit Stays, Ventilation, and Death Among Patients With Immune-mediated Inflammatory Diseases Compared to Controls.
    Eder L; Croxford R; Drucker AM; Mendel A; Kuriya B; Touma Z; Johnson SR; Cook R; Bernatsky S; Haroon N; Widdifield J
    J Rheumatol; 2022 May; 49(5):523-530. PubMed ID: 35105713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding COVID-19 Risk in Patients With Immune-Mediated Inflammatory Diseases: A Population-Based Analysis of SARS-CoV-2 Testing.
    Eder L; Croxford R; Drucker AM; Mendel A; Kuriya B; Touma Z; Johnson SR; Cook R; Bernatsky S; Haroon N; Widdifield J
    Arthritis Care Res (Hoboken); 2023 Feb; 75(2):317-325. PubMed ID: 34486829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Vaccination Uptake Among Individuals With Immune-mediated Inflammatory Diseases in Ontario, Canada, Between December 2020 and October 2021: A Population-based Analysis.
    Widdifield J; Eder L; Chen S; Kwong JC; Hitchon C; Lacaille D; Aviña-Zubieta JA; Svenson LW; Bernatsky S
    J Rheumatol; 2022 May; 49(5):531-536. PubMed ID: 35034001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Developing Additional Immune-Mediated Manifestations: A Retrospective Matched Cohort Study.
    Aletaha D; Epstein AJ; Skup M; Zueger P; Garg V; Panaccione R
    Adv Ther; 2019 Jul; 36(7):1672-1683. PubMed ID: 31102202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous Thromboembolism After COVID-19 Infection Among People With and Without Immune-Mediated Inflammatory Diseases.
    Khan R; Kuenzig ME; Tang F; Im JHB; Widdifield J; McCurdy JD; Kaplan GG; Benchimol EI
    JAMA Netw Open; 2023 Oct; 6(10):e2337020. PubMed ID: 37812417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine learning to understand risks for severe COVID-19 outcomes: a retrospective cohort study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US health-care system.
    Wei Q; Mease PJ; Chiorean M; Iles-Shih L; Matos WF; Baumgartner A; Molani S; Hwang YM; Belhu B; Ralevski A; Hadlock J
    Lancet Digit Health; 2024 May; 6(5):e309-e322. PubMed ID: 38670740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort study.
    Galloway J; Barrett K; Irving P; Khavandi K; Nijher M; Nicholson R; de Lusignan S; Buch MH
    RMD Open; 2020 Sep; 6(3):. PubMed ID: 32994362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propensity-Matched Analysis of the Risk of Age-Related Macular Degeneration with Systemic Immune-Mediated Inflammatory Disease.
    Shukla P; Russell MW; Muste JC; Shaia JK; Kumar M; Nowacki AS; Hajj-Ali RA; Singh RP; Talcott KE
    Ophthalmol Retina; 2024 Aug; 8(8):778-785. PubMed ID: 38320691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and temporal trends of co-occurring personality disorder diagnoses in immune-mediated inflammatory diseases.
    Blaney C; Sommer J; El-Gabalawy R; Bernstein C; Walld R; Hitchon C; Bolton J; Sareen J; Patten S; Singer A; Lix L; Katz A; Fisk J; Marrie RA;
    Epidemiol Psychiatr Sci; 2020 Jan; 29():e84. PubMed ID: 31915099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher Incidence Rates of Comorbidities in Patients with Psoriatic Arthritis Compared with the General Population Using U.S. Administrative Claims Data.
    Kaine J; Song X; Kim G; Hur P; Palmer JB
    J Manag Care Spec Pharm; 2019 Jan; 25(1):122-132. PubMed ID: 29694270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark.
    Burisch J; Jess T; Egeberg A
    Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2704-2712.e3. PubMed ID: 30936024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of immune-mediated inflammatory diseases following COVID-19: a matched cohort study in UK primary care.
    Syed U; Subramanian A; Wraith DC; Lord JM; McGee K; Ghokale K; Nirantharakumar K; Haroon S
    BMC Med; 2023 Sep; 21(1):363. PubMed ID: 37735654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiological data and medical care situation of patients with chronic inflammatory diseases in Germany : Real-world evidence on prevalence, disease combinations, care].
    Riemekasten G; Schmelz R; Schäkel K; Thaci D; Schreiber S; Röcken M; Bartz H; Ploner T; Liao X; Weber V; Manz KC; Burkhardt H; Leipe J
    Z Rheumatol; 2024 Sep; 83(7):578-586. PubMed ID: 38071271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multidisciplinary registry of patients with autoimmune and immune-mediated diseases with symptomatic COVID-19 from a single center.
    Sarmiento-Monroy JC; Espinosa G; Londoño MC; Meira F; Caballol B; Llufriu S; Carrasco JL; Moll-Udina A; Quintana LF; Giavedoni P; Ramírez J; Inciarte-Mundo J; Solana E; Blanco Y; Martinez-Hernandez E; Sepúlveda M; Llorenç V; Prieto-González S; Espígol-Frigolé G; Milisenda JC; Cid MC; Mascaró JM; Blanco I; Barberá JA; Sibila O; Gratacos-Ginès J; Adán A; Agustí A; Sanmartí R; Panés J; Cervera R; Vila J; Soriano A; Gómez-Puerta JA;
    J Autoimmun; 2021 Feb; 117():102580. PubMed ID: 33338707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19.
    Izadi Z; Brenner EJ; Mahil SK; Dand N; Yiu ZZN; Yates M; Ungaro RC; Zhang X; Agrawal M; Colombel JF; Gianfrancesco MA; Hyrich KL; Strangfeld A; Carmona L; Mateus EF; Lawson-Tovey S; Klingberg E; Cuomo G; Caprioli M; Cruz-Machado AR; Mazeda Pereira AC; Hasseli R; Pfeil A; Lorenz HM; Hoyer BF; Trupin L; Rush S; Katz P; Schmajuk G; Jacobsohn L; Seet AM; Al Emadi S; Wise L; Gilbert EL; Duarte-García A; Valenzuela-Almada MO; Isnardi CA; Quintana R; Soriano ER; Hsu TY; D'Silva KM; Sparks JA; Patel NJ; Xavier RM; Marques CDL; Kakehasi AM; Flipo RM; Claudepierre P; Cantagrel A; Goupille P; Wallace ZS; Bhana S; Costello W; Grainger R; Hausmann JS; Liew JW; Sirotich E; Sufka P; Robinson PC; Machado PM; Griffiths CEM; Barker JN; Smith CH; Yazdany J; Kappelman MD; ;
    JAMA Netw Open; 2021 Oct; 4(10):e2129639. PubMed ID: 34661663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal-fetal outcomes in patients with immune-mediated inflammatory diseases, with consideration of comorbidities: a retrospective cohort study in a large U.S. healthcare system.
    Hwang YM; Wei Q; Piekos SN; Vemuri B; Molani S; Mease P; Hood L; Hadlock J
    EClinicalMedicine; 2024 Feb; 68():102435. PubMed ID: 38586478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immune-mediated inflammatory diseases in Germany : A cross-sectional analysis of comorbidities and pharmacotherapy].
    Leipe J; Schmelz R; Riemekasten G; Thaçi D; Henes J; Schäkel K; Pinter A; Sticherling M; Wegner J; Fusco S; Linke M; Weber V; Manz KC; Bartz H; Roecken M; Schmidt S; Hoyer BF
    Z Rheumatol; 2024 Apr; 83(3):200-209. PubMed ID: 36600054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post COVID-19 hospitalizations in patients with chronic inflammatory diseases - A nationwide cohort study.
    Nørgård BM; Zegers FD; Nielsen J; Kjeldsen J
    J Autoimmun; 2021 Dec; 125():102739. PubMed ID: 34757259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased incidence of psychiatric disorders in immune-mediated inflammatory disease.
    Marrie RA; Walld R; Bolton JM; Sareen J; Walker JR; Patten SB; Singer A; Lix LM; Hitchon CA; El-Gabalawy R; Katz A; Fisk JD; Bernstein CN;
    J Psychosom Res; 2017 Oct; 101():17-23. PubMed ID: 28867419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of COVID-19 Infection and Vaccination Among Individuals With Myasthenia Gravis.
    Alcantara M; Koh M; Park AL; Bril V; Barnett C
    JAMA Netw Open; 2023 Apr; 6(4):e239834. PubMed ID: 37097637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.